본문 바로가기

US · 21 CFR

21 CFR 606.60

Equipment.

21 CFR Part 606 › Subpart D—Equipment

조항 원문

(a) Equipment used in the collection, processing, compatibility testing, storage and distribution of blood and blood components shall be maintained in a clean and orderly manner and located so as to facilitate cleaning and maintenance. The equipment shall be observed, standardized and calibrated on a regularly scheduled basis as prescribed in the Standard Operating Procedures Manual and shall perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in this chapter for blood and blood products.

(b) Equipment that shall be observed, standardized and calibrated with at least the following frequency, include but are not limited to:

Equipment Performance check Frequency Frequency of calibration

Temperature recorder Compare against thermometer Daily As necessary.

Refrigerated centrifuge Observe speed and temperature Each day of use Do.

Hematocrit centrifuge Standardize before initial use, after repairs or adjustments, and annually. Timer every 3 mo.

General lab centrifuge Tachometer every 6 mo.

Automated blood-typing machine Observe controls for correct results Each day of use

Hemoglobinometer Standardize against cyanmethemoglobin standard ......do

Refractometer Standardize against distilled water ......do

Blood container scale Standardize against container of known weight ......do As necessary.

Water bath Observe temperature ......do Do.

Rh view box ......do ......do Do.

Autoclave ......do Each time of use Do.

Serologic rotators Observe controls for correct results Each day of use Speed as necessary.

Laboratory thermometers Before initial use.

Electronic thermometers Monthly.

Vacuum blood agitator Observe weight of the first container of blood filled for correct results Each day of use Standardize with container of known mass or volume before initial use, and after repairs or adjustments.

(c) Equipment employed in the sterilization of materials used in blood collection or for disposition of contaminated products shall be designed, maintained and utilized to ensure the destruction of contaminating microorganisms. The effectiveness of the sterilization procedure shall be no less than that achieved by an attained temperature of 121.5 °C (251 °F) maintained for 20 minutes by saturated steam or by an attained temperature of 170 °C (338 °F) maintained for 2 hours with dry heat.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

각주·출처 표기

  • [40 FR 53532, Nov. 18, 1975; 40 FR 55849, Dec. 2, 1975, as amended at 45 FR 9261, Feb. 12, 1980; 57 FR 11263, Apr. 2, 1992; 57 FR 12862, Apr. 13, 1992]

출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-16

Weekly Newsletter

FDA·EU·식약처 실사 지적, 매주 받아 보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

확인 메일의 버튼을 누르면 구독이 완료됩니다 · 언제든 해지할 수 있습니다